Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2012 1
2013 1
2020 1
2021 2
2022 2
2023 1
2024 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
Hadoux J, Elisei R, Brose MS, Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J, Wirth LJ; LIBRETTO-531 Trial Investigators. Hadoux J, et al. N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870969 Clinical Trial.
Cardio-oncology Issues in Lymphoma Patients.
Bryne A, Lambert J, Yellon D, Walker M, Sivabalasingham S, Ghosh AK. Bryne A, et al. Among authors: sivabalasingham s. Isr Med Assoc J. 2022 Mar;24(3):159-164. Isr Med Assoc J. 2022. PMID: 35347928 Free article. Review.
Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK (IoN): a randomised, multicentre, non-inferiority trial.
Mallick U, Newbold K, Beasley M, Garcez K, Wadsley J, Johnson SJ, Stephenson T, Gaze M, Goodman A, Jefferies S, Sivabalasingham S, Slevin N, Wilkinson DP, Macias-Fernandez E, Power D, Roques T, Speed L, Nutting C, Mochloulis G, Gerrard G, Candish C, Morgan S, Tripathi D, Truran P, Arthur C, Wieczorek A, Madhavan K, Maclean J, Boote D, Kim D, Pascoe A, Pitiyage G, Forsyth S, Ambrose E, Chang E, Farnell K, Hackshaw A. Mallick U, et al. Among authors: sivabalasingham s. Lancet. 2025 Jul 5;406(10498):52-62. doi: 10.1016/S0140-6736(25)00629-4. Epub 2025 Jun 18. Lancet. 2025. PMID: 40543520 Free article. Clinical Trial.
Comprehensive Diagnosis and Management of POEMS Syndrome.
D'Sa S, Khwaja J, Keddie S, Keh RY, Smyth D, Ronneberger R, Dubash S, Sivabalasingham S, Wan S, Hoskote C, Baldeweg S, Sive J, Lunn MP. D'Sa S, et al. Among authors: sivabalasingham s. Hemasphere. 2022 Oct 31;6(11):e796. doi: 10.1097/HS9.0000000000000796. eCollection 2022 Nov. Hemasphere. 2022. PMID: 36340912 Free PMC article. Review.
Outcome and feasibility of radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T in the UK.
Kuhnl A, Roddie C, Kirkwood AA, Chaganti S, Norman J, Lugthart S, Osborne W, Gibb A, Gonzalez Arias C, Latif A, Uttenthal B, Seymour F, Jones C, Springell D, Brady JL, Illidge T, Stevens A, Alexander E, Hawley L, O'Rourke N, Bedi C, Prestwich R, Frew J, Burns D, O'Reilly M, Sanderson R, Sivabalasingham S, Mikhaeel NG. Kuhnl A, et al. Among authors: sivabalasingham s. Br J Haematol. 2024 Aug;205(2):483-494. doi: 10.1111/bjh.19453. Epub 2024 Apr 9. Br J Haematol. 2024. PMID: 38594876
The Role of Radiotherapy for Patients With Multiple Myeloma in the Modern Era: A Real World Single-Centre Experience.
Mehta D, Gabriel M, Adu-Poku N, Kanellias N, Papanikolaou X, Sive J, Rabin N, Popat R, Boyle EM, Lee L, Yong K, Parcharidou A, Sivabalasingham S, Keshwani K, Xu K, Kyriakou C. Mehta D, et al. Among authors: sivabalasingham s. EJHaem. 2025 Oct 4;6(5):e70141. doi: 10.1002/jha2.70141. eCollection 2025 Oct. EJHaem. 2025. PMID: 41049575 Free PMC article.